COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

BACKGROUND: Since vaccination against coronavirus disease 2019 (COVID-19) became available, risks related to vaccinating patients with multiple sclerosis (MS) need to be carefully assessed. OBJECTIVE: Characterize safety and occurrence of immediate relapses following COVID-19 vaccination in a large...

Descripción completa

Detalles Bibliográficos
Autores principales: Achiron, Anat, Dolev, Mark, Menascu, Shay, Zohar, Daniela-Noa, Dreyer-Alster, Sapir, Miron, Shmuel, Shirbint, Emanuel, Magalashvili, David, Flechter, Shlomo, Givon, Uri, Guber, Diana, Stern, Yael, Polliack, Michael, Falb, Rina, Gurevich, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114441/
https://www.ncbi.nlm.nih.gov/pubmed/33856242
http://dx.doi.org/10.1177/13524585211003476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114441/
https://www.ncbi.nlm.nih.gov/pubmed/33856242
http://dx.doi.org/10.1177/13524585211003476

Ejemplares similares